Les troubles anxieux : Orientations futures de la recherche et du traitement

Prochaine | Précédente | Table des matières

Bibliographie

American Psychiatric Association (1980). Manuel diagnostique et statistique des troubles mentaux (3e éd.). Washington, D.C.: APA.

American Psychiatric Association (1987). Manuel diagnostique et statistique des troubles mentaux (3e éd., révisée). Washington, D.C.: APA.

American Psychiatric Association (1994). Manuel diagnostique et statistique des troubles mentaux (4e éd.). Washington, D.C.: Author.

Angst, J., et Vollrath, M. (1991). The natural history of anxiety disorders. Acta Psychiatrica Scandinavica, 84, 446-452.

Antony, M.M., et Barlow, D.H. (1996). Emotion theory as a framework for explaining panic attacks and panic disorder. In R.M. Rapee (Ed.), Current controversies in the anxiety disorders. New York: Guilford Press.

Antony, M.M., et Barlow, D.H. (in press). Social and specific phobias . In A. Tasman, J. Kay, et J.A. Lieberman (Eds.), Psychiatry. Orlando, FL: W.B. Saunders Company.

Antony, M.M., Brown, T.A., et Barlow, D.H. (1992). Current perspectives on panic and panic disorder. Current Directions in Psychological Science, 1, 79-82.

Antony, M.M., Craske, M.G., et Barlow, D.H. (1995). Mastery of your specific phobia. Albany, NY: Graywind Publications.

Aronson, T.A., et Craig, T.J. (1986). Cocaine precipitation of panic disorder. American Journal of Psychiatry, 143, 643-645.

Aronson, T.A., et Logue, C.M. (1987). On the longitudinal course of panic disorder: Developmental history and predictors of phobic complications. Comprehensive Psychiatry, 28, 344-355.

Ballenger, J.C., Burrows, G.D., DuPont, R.L., Lesser, I.M., Noyes, R., Jr., Pecknold, J.C., Rifkin, A., et Swinson, R. (1988). Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. Archives of General Psychiatry, 45, 413-422.

Barlow, D.H. (1988). Anxiety and its disorders: The nature and treatment of anxiety and panic. New York: Guilford Press.

Barlow, D.H., O'Brien, G.T., et Last, C.G. (1984). Couples treatment of agoraphobia. Behaviour Therapy, 15, 41-58.

Barlow, D.H., Rapee, R.M., et Brown, T.A. (1992). Behavioral treatment of generalized anxiety disorder. Behavior Therapy, 23, 551-570.

Basoglu, M., Marks, I.M., Kilic, C., Brewin, C.R., et Swinson, R.P. (1994). Alprazolam and exposure for panic disorder with agoraphobia: Attribution of improvement to medication predicts subsequent relapse. British Journal of Psychiatry, 164, 652-659.

Beauclair, L., Fontaine, R., Annable, L., Holobow, N., et Chouinard, G. (1994). Clonazepam in the treatment of panic disorder: A double-blind, placebo-controlled trail investigating the correlation between clonazepam concentrations in plasma and clinical response. Journal of Clinical Psychopharmacology, 14, 111-118.

Bland, R.C., Orn, H., et Newman, S.C. (1988). Lifetime prevalence of psychiatric disorders in Edmonton. Acta Psychiatrica Scandinavica, 77(Suppl. 338), 24-32.

Borkovec, T.D., et Costello, E. (1993). Efficacy of applied relaxation and cognitive-behavioral therapy in the treatment of generalized anxiety disorder. Journal of Consulting and Clinical Psychology, 61, 611-619.

Borkovec, T.D., Mathews, A.M., Chambers, A., Ebrahimi, S., Lytle, R., et Nelson, R. (1987). The effects of relaxation training with cognitive or nondirective therapy and the role of relaxation-induced anxiety in the treatment of generalized anxiety. Journal of Consulting and Clinical Psychology, 55, 883-888.

Bourdon, K.H., Boyd, J.H., Rae, D.S., Burns, B.J., Thompson, J.W., et Locke, B.Z. (1988). Gender differences in phobias: Results of the ECA community study. Journal of Anxiety Disorders, 2, 227-241.

Bourque, P. et Ladouceur, R. (1980). An investigation of various performance-based treatments with agoraphobics. Behaviour Research and Therapy, 18, 161-170.

Brown, T.A., Antony, M.M., et Barlow, D.H. (1995). Diagnostic comorbidity in panic disorder: Effect on treatment outcome and course of comorbid diagnoses following treatment. Journal of Consulting and Clinical Psychology, 63, 408-418.

Bruch, M.A. (1989). Familial and developmental antecedents of social phobia: Issues and findings. Clinical Psychology Review, 9, 37-47.

Bruch, M.A., et Heimberg, R.G. (1994). Differences in perceptions of parental and personal characteristics between generalized and nongeneralized social phobics. Journal of Anxiety Disorders, 8, 155-168.

Butler, G., Cullington, A., Munby, M., Amies, P., et Gelder, M. (1984). Exposure and anxiety management in the treatment of social phobia. Journal of Consulting and Clinical Psychology, 52, 642-650.

Carter, C.S., Fawcett, J., Hertzman, M., Papp, L.A., Jones, W., Patterson, W.M., Swinson, R. P., Weise, C.C., Maddock, R.J., Denahan, A.Q., et Liebowitz, M. (1995). Adinazolam-SR in panic disorder with agoraphobia: Relationship of daily dose to efficacy. Journal of Clinical Psychopharmacology, 56, 202-210.

Cerny, J.A., Barlow, D.H., Craske, M.G., et Himadi, W.G. (1987). Couples treatment of agoraphobia: A two-year follow-up. Behaviour Therapy, 18, 401-415.

Chen, Y.-W., et Dilsaver, S.C. (1995). Comorbidity of panic disorder in bipolar illness: Evidence from the Epidemiological Catchment Area Survey. American Journal of Psychiatry, 152, 280-282.

Chouinard, G., Goodman, W., Greist, J., Jenike, M., Rasmussen, S., White, K., Hackett, E., Gaffney, M., et Bick, P.A. (1990). Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmocology Bulletin, 26, 279-284.

Clark, D.M., Salkovskis, P.M., Hackmann, A., Middleton, H., Anastasiades, P., et Gelder, M. (1994). A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. British Journal of Psychiatry, 164, 759-769.

Clomipramine Collaborative Study Group (1991). Clomipramine in the treatment of patients with obsessive-compulsive disorder. Archives of General Psychiatry, 48, 730-738.

Clum, G.A., Clum, G.A., et Surls, R. (1993). A meta-analysis of treatments for panic disorder. Journal of Consulting and Clinical Psychology, 61, 317-326.

Cohen, S.D., Monteiro, W., et Marks, I.M. (1984). Two-year follow-up of agoraphobics after exposure and imipramine. British Journal of Psychiatry, 144, 276-281.

Cottraux, J., Mollard, E., Bouvard, M., Marks, I., Sluys, M., Nury, A., Douge, R., et Cialdella, P. (1990). A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder. International Clinical Psychopharmocology, 5, 17-30.

Cox, B.J., Norton, G.R., Swinson, R.P., et Endler, N.S. (1990). Substance abuse and panic-related anxiety: A critical review. Behaviour Research and Therapy, 28, 385-393.

Cox, B.J., Swinson, R.P., Morrison, B., et Lee, P.S. (1993). Clomipramine, fluoxetine, and behavior therapy in the treatment of obsessive-compulsive disorder: A meta-analysis. Journal of Behavioral Therapy and Experimental Psychiatry, 24, 149-153.

Cross-National Collaborative Panic Study, Second Phase Investigators (1992). Drug treatment of panic disorder. British Journal of Psychiatry, 160, 191-202.

Davidson, J., Kudler, H., Smith, R., Mahorney, S. L., Lipper, S., Hammett, E., Saunders, W. B., et Cavenar, J.O., Jr. (1990). Treatment of posttraumatic stress disorder with amitriptyline and placebo. Archives of General Psychiatry, 47, 259-266.

Davidson, J.R.T., Potts, N., Richichi, E., Krishnan, R., Ford, S.M., Smith, R., et Wilson, W.H. (1993). Treatment of social phobia with clonazepam and placebo. Journal of Clinical Psychopharmacology, 13, 423-428.

de Beurs, E., van Balkom, A.J., Lange, A., Koele, P., et van Dyke, R. (1995). Treatment of panic disorder with agoraphobia: Comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone. American Journal of Psychiatry, 152, 683-691.

Durham, R.C., Murphy, T., Allan, T., Richard, K., Treliving, L.R., et Fenton, G.W. (1994). Cognitive therapy, analytic psychotherapy and anxiety management training for generalized anxiety disorder. British Journal of Psychiatry, 165, 315-323.

Fahlen, T., Nilsson, H.L., Borg, K., Humble, M., et Pauli, U. (1995). Social phobia: The clinical efficacy and tolerability of the monoamine oxidase-A and serotonin uptake inhibitor Brofaromine. Acta Psychiatrica Scandinavica, 92, 351-358.

Fals-Stewart, W., Marks, A.P., et Schafer, J. (1993). A comparison of behavioral group therapy and individual behavior therapy in treating obsessive-compulsive disorder. Journal of Nervous and Mental Disease, 181, 189-193.

Faravelli, C., et Pallanti, S. (1989). Recent life events and panic disorder. American Journal of Psychiatry, 146, 622-626.

Fava, G.A., Zielezny, M., Luria, E., et Canestrari, R. (1988). Obsessive-compulsive symptoms in agoraphobia: Changes with treatment. Psychiatry Research, 23, 57-63.

Feske, U., et Chambless, D.L. (1995). Cognitive-behavioral versus exposure only treatment for social phobia: A meta-analysis. Behavior Therapy, 26, 695-720.

Foa, E.B., et Goldstein, A. (1978). Continuous exposure and complete response prevention in the treatment of obsessive-compulsive neurosis. Behavior Therapy, 9, 821-829.

Foa, E.B., Herst-Ikeda, D., et Perry, K.J. (1995). Evaluation of a brief cognitive-behavioral program for the prevention of chronic PTSD in recent assault victims. Journal of Consulting and Clinical Psychology, 63, 948-955.

Fyer, A.J., Mannuzza, S., Chapman, T.F., Martin, L.Y., et Klein, D.F. (1995). Specificity in familial aggregation of phobic disorders. Archives of General Psychiatry, 52, 564-573.

Gelernter, C.S., Uhde, T.W., Cimbolic, P., Arnkoff, D.B., Vittone, B.J., et Tancer, M.E. (1991). Cognitive-behavioral and pharmacological treatments of social phobia: A controlled study. Archives of General Psychiatry, 48, 938-945.

Gerlsma, C., Emmelkamp, P.M.G., et Arrindell, W.A. (1990). Anxiety, depression, and perception of early parenting: A meta-analysis. Clinical Psychology Review, 10, 251-277.

Gould, R.A., Clum, G.A., et Shapiro, D. (1993). The use of bibliotherapy in the treatment of panic: A preliminary investigation. Behavior Therapy, 24, 241-252.

Hecker, J.E., Fink, C.M., et Fritzler, B.K. (1993). Acceptability of panic disorder treatments: A survey of family practice physicians. Journal of Anxiety Disorders, 7, 373-384.

Heimberg, R.G., Dodge, C.S., Hope, D.A., Kennedy, C.R., et Zollo, L.J. (1990). Cognitive-behavioral group treatment for social phobia: Comparison with a credible placebo control. Cognitive Therapy and Research, 14, 1-23.

Heimberg, R.G., Juster, H.R., Brown, E.J., Holle, C., Schneier, F.R., et Gitow, A. (1994, November). Cognitive-behavioral versus pharmacological treatment of social phobia: Posttreatment and follow-up effects. Paper presented at the Annual Meeting of the Association for Advancement of Behavior Therapy, San Diego, CA.

Hoehn-Saric, R., McLeod, D. R., et Zimmerli, W.D. (1988). Differential effects of alprazolam and imipramine in generalized anxiety disorder: Somatic versus psychic symptoms. Journal of Clinical Psychiatry, 49, 293-301.

Jerremalm, A., Jansson, L., et Öst, L.-G. (1986). Individual response patterns and the effects of different behavioral methods in the treatment of dental phobia. Behaviour Research and Therapy, 24, 587-596.

Johnston, D.G., Troyer, I.E., et Whitsett, S.F. (1988). Clomipramine treatment of agoraphobic women: An eight-week controlled trial. Archives of General Psychiatry, 45, 453-459.

Katzelnick, D.J., Kobak, K.A., Greist, J.H., Jefferson, J.W., Mantle, J.M., et Serlin, R.C. (1995). Sertraline for social phobia: A double-blind, placebo-controlled crossover study. American Journal of Psychiatry, 152, 1368-1371.

Keane, T.M., Fairbank, J.A., Caddell, J.M., et Zimering, R.T. (1989). Implosive (flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans. Behavior Therapy, 20, 245-260.

Kendler, K.S., Neale, M.C., Kessler, R.C., Heath, A.C., et Eaves, L.J. (1992). The genetic epidemiology of phobias in women: The interrelationship of agoraphobia, social phobia, situational phobia, and simple phobia. Archives of General Psychiatry, 49, 273-281.

Kessler R.C., McGonagle K.A., Zhao S., Nelson, C.B., Hughes, M., Eshleman, S., Wittchen H.-U., et Kendler, K. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8-19.

Keyl, P.M., et Eaton, W.W. (1990). Risk factors for the onset of panic disorder and panic attacks in a prospective, population-based study. American Journal of Epidemiology, 131, 301-311.

Klein, E., Colin, V., Stolk, J., et Lenox, R.H. (1994). Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: Vulnerability and effect of carbamazepine. American Journal of Psychiatry, 151, 1760-1766.

Kosten, T.R., Frank, J.B., Dan, E., McDougle, C.J., et Giller, E.L., Jr. (1991). Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. The Journal of Nervous and Mental Disease, 179, 366-370.

Kushner, M.G., Sher, K.J., et Beitman, B.D. (1990). The relation between alcohol problems and the anxiety disorders. American Journal of Psychiatry, 147, 685-695.

Lelliott, P.T., Marks, I.M., Monteiro, W.O., Tsakiris, F., et Noshirvani, H. (1987). Agoraphobics 5 years after imipramine and exposure: Outcome and predictors. Journal of Nervous and Mental Disease, 175, 599-605.

Leon, A.C., Portera, L., et Weissman, M.M. (1995). The social costs of anxiety disorders. British Journal of Psychiatry, 166(suppl. 27). 19-22.

Liebowitz, M.R., Schneier, F., Campeas, R., Hollander, E., Hatterer, J., et Fyer, A.J. (1992). Phenelzine vs atenolol in social phobia: A placebo-controlled comparison. Archives of General Psychiatry, 49, 290-300.

MacDonald, A.M., et Murray, R.M. (1994). The genetics of anxiety disorders. In B.B. Wolman et G. Stricker (Eds.), Anxiety and related disorders: A handbook. New York: John Wiley and Sons.

Marks, I.M., Gray, S., Cohen, D., Hill, R., Mawson, D., Ramm, E., et Stern, R.S. (1983). Imipramine and brief therapist-aided exposure in agoraphobics having self-exposure homework. Archives of General Psychiatry, 40, 153-162.

Marks, I.M., Lelliott, P., Basoglu, M., Noshirvani, H., Monteiro, W., Cohen, D., et Kasvikis, Y. (1988). Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals. British Journal of Psychiatry, 152, 522-534.

Marks, I.M., Swinson, R.P., Basoglu, M., Kuch, K., Noshirvani, H., O'Sullivan, G., Lelliott, P.T., Kirby, M., McNamee, G., Sengun, S., et Wickwire, K. (1993). Alprazolam and exposure alone and combined in panic disorder with agoraphobia: A controlled study in London and Toronto. British Journal of Psychiatry, 162, 776-787.

Mavissakalian, M.R., et Perel, J.M. (1995). Imipramine treatment of panic disorder with agoraphobia: Dose ranging and plasma level-response relationships. American Journal of Psychiatry, 152, 673-682.

McCarley, T., Steinberg, A., Spears, M., et Essock-Vitale, S. (1987). Integrating biological and psychosocial therapies: A survey of psychiatric training, practice, and attitudes. Journal of Psychiatric Education, 11, 43-53.

Ministère de la Santé de l'Ontario. (1994). L'enquête sur la santé en Ontario 1990 : Supplément-Santé mentale. Toronto: Ministère de la santé de l'Ontario.

Newman, M.G., Hofmann, S.G., Trabert, W., Roth, W.T., et Taylor, C.B. (1994). Does behavioral treatment of social phobia lead to cognitive changes? Behavior Therapy, 25, 503-517.

Noyes, R., Jr., DuPont, R.L., Pecknold, J.C., Rifkin, A., Rubin, R.T., Swinson, R.P., Ballenger, J.C., et Burrows, G.D. (1988). Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial: Patient acceptance, side effects, and safety. Archives of General Psychiatry, 45, 423-428.

Noyes, R., Jr., Garvey, M.J., Cook, B., et Suelzer, M. (1991). Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. American Journal of Psychiatry, 148, 517-523.

Öst, L.-G. (1989). One-session treatment for specific phobias. Behaviour Research and Therapy, 27, 1-7.

Öst, L.-G., Fellenius, J., et Sterner, U. (1991). Applied tension, exposure in vivo, and tension-only in the treatment of blood phobia. Behaviour Research and Therapy, 29, 561-574.

Öst, L.-G., Johansson, J., et Jerremalm, A. (1982). Individual response patterns and the effects of different behavioral methods in the treatment of claustrophobia. Behaviour Research and Therapy, 20, 445-460.

Öst, L.-G., Lindahl, I.L., Sterner, U., et Jerremalm, A. (1984). Exposure in vivo vs. applied relaxation in the treatment of blood phobia. Behaviour Research and Therapy, 22, 205-216.

Öst, L.-G., Salkovskis, P.M., et Hellström, K. (1991). One-session therapist-directed exposure vs. self-exposure in the treatment of spider phobia. Behavior Therapy, 22, 407-422.

Otto, M.W., Pollack, M.H., Sachs, G.S., Reiter, S.R., Meltzer-Brody, S., et Rosenbaum, J.F. (1993). Discontinuation of benzodiazepine treatment: Efficacy of cognitive-behavioral therapy for patients with panic disorder. American Journal of Psychiatry, 150, 1485-1490.

Pauls, D.L., Alsobrook, J.P., Goodman, W., Rasmussen, S., et Leckman, J.F. (1995). A family study of obsessive-compulsive disorder. American Journal of Psychiatry, 152, 76-84.

Pecknold, J.C., Swinson, R.P., Kuch, K., et Lewis, C.P. (1988). Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial: Discontinuation effects. Archives of General Psychiatry, 45, 429-436.

Perse, T.L., Greist, J.H., Jefferson, J.W., Rosenfeld, R., et Dar, R. (1987). Fluvoxamine treatment of obsessive-compulsive disorder. American Journal of Psychiatry, 144, 1543-1548.

Pollard, C.A., Henderson, J.G., Frank, M., et Margolis, R.B. (1989). Help-seeking patterns of anxiety disordered individuals in the general population. Journal of Anxiety Disorders, 3, 131-138.

Pollard, C.A., Pollard, H.J., et Corn, K.J. (1989). Panic onset and major events in the lives of agoraphobics: A test of contiguity. Journal of Abnormal Psychology, 98, 318-321.

Power, K.G., Simpson, R.J., Swanson, V., et Wallace, L.A. (1990). A controlled comparison of cognitive-behaviour therapy, diazepam, and placebo, alone and in combination, for the treatment of generalized anxiety disorder. Journal of Anxiety Disorders, 4, 267-292.

Rickels, K., Downing, R., Schweizer, E., et Hassman, H. (1993). Antidepressants for the treatment of generalized anxiety disorder. Archives of General Psychiatry, 50, 884-895.

Rickels, K., Schweizer, E., Weiss, S., et Zavodnick, S. (1993). Maintenance drug treatment for panic disorder: Short- and long-term outcome after drug taper. Archives of General Psychiatry, 50, 61-68.

Rickels, K., Weisman, K., Norstad, N., Singer, M., Stoltz, D., et Brown, A. (1982). Buspirone and diazepam in anxiety: A controlled study. Journal of Clinical Psychiatry, 43, 81-86.

Robins, L.N., Helzer, J.E., Croughan, J.L., et Ratcliff, K.S. (1981). National Institute of Mental Health Diagnostic Interview Schedule: Its history, characteristics and validity. Archives of General Psychiatry, 38, 381-389.

Robins, L.N., Helzer, J.E., Weissman, M.M., Orvaschel, H., Gruenberg, E., Burke, J.D., et Regier, D.A. (1984). Lifetime prevalence of specific psychiatric disorders in three sites. Archives of General Psychiatry, 41, 949-958.

Robins, L.N., Wing, J., Wittchen, H.U., et Helzer, J.E. (1988). The Composite International Diagnostic Interview: An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Archives of General Psychiatry, 45, 1069-1077.

Romeder, Jean-Marie. (1993). Of surveys and definitions of self-help and mutual aid. Self-help/mutual aid for seniors: Research challenges, report of the discussion session at the Canadian Association of Gerontology in Montreal on October 30, 1993. Ottawa: Self-Help Canada.

Roy-Byrne, P.P., et Uhde, T.W. (1988). Exogenous factors in panic disorder: Clinical and research implications. Journal of Clinical Psychiatry, 49, 56-61.

Roy-Byrne, P.P., Geraci, M., et Uhde, T.W. (1986). Life events and the onset of panic disorder. American Journal of Psychiatry, 143, 1424-1427.

Sacchetti, E., Zerbini, O., Banfi, F., et Tansella, M. (1994). Overlap of buspirone with lorazepam, diazepam and bromazepam in patients with generalized anxiety disorder: Findings from a controlled, multicentre double-blind study. Human Psychopharmacology, 9, 409-422.

Salvador-Carulla, Segui, J., Fernandez-Cano, P., et Canet, J. (1995). Costs and offset effect in panic disorders. British Journal of Psychiatry, 166(suppl. 27), 23-28

Sanderson, W.C., Beck, A.T., et Betz, F. (1991, November). Prevalence of personality disorders among patients with anxiety disorders. Paper presented at the annual meeting of the Association for Advancement of Behavior Therapy, New York, NY.

Sanderson, W.C., Di Nardo, P.A., Rapee, R.M., et Barlow, D.H. (1990). Syndrome comorbidity in patients diagnosed with a DSM-III-R anxiety disorder. Journal of Abnormal Psychology, 99, 308-312.

Santé Canada. (1994). Évaluation des programmes de traitement de la schizophrénie : Une perspective économique médicale. Ottawa : Ministre des Approvisionnements et Services Canada.

Santé Canada. (1996). Évaluation de la qualité de vie des personnes atteintes de troubles mentaux chroniques : Analyse critique des mesures et des méthodes. Ottawa : Ministre des Approvisionnements et Services du Canada.

Schweizer, E., Pohl, R., Balon, R., Fox, I., Rickels, K., et Yeragani, V.K. (1990). Lorazepam vs. alprazolam in the treatment of panic disorder. Pharmacopsychiatry, 23, 90-93.

Siegel, L., Jones, W.C., et Wilson, J.O. (1990). Economic and life consequences experienced by a group of individuals with panic disorder. Journal of Anxiety Disorders, 4, 201-211.

Silove, Parker, Hadzi-Pavlovic, Manicavasagar, et Blaszczynski, A. (1991). Parental representations of patients with panic disorder and generalized anxiety disorder. British Journal of Psychiatry, 159, 835-841.

Simon, G., Ormel, J., VonKorff, M., et Barlow, W. (1995). Health care costs associated with depressive and anxiety disorders in primary care. American Journal of Psychiatry, 152, 352-357.

Stein, D.J., Hollander, E., et Skodol, A.E. (1993). Anxiety disorders and personality disorders: A review. Journal of Personality Disorders, 7, 87-104.

Swinson, R.P., Cox, B.J., et Woszczyna, C.B. (1992). Use of medical services and treatment for panic disorder with agoraphobia and for social phobia. Canadian Medical Association Journal, 147, 878-883.

Swinson, R.P., Cox, B.J., Kerr, S.A., Kuch, K., et Fergus, K.D. (1992). A survey of anxiety disorders clinics in Canadian hospitals. Canadian Journal of Psychiatry, 37, 188-191.

Swinson, R.P., Fergus, K.D., Cox, B.J., et Wickwire, K. (1995). Efficacy of telephone-administered behavioral therapy for panic disorder with agoraphobia. Behaviour Research and Therapy, 33, 465-469.

Telch, M.J., Agras, W.S., Taylor, C.B., Roth, W.T., et Gallen, C.C. (1985). Combined pharmacological and behavioral treatment for agoraphobia. Behaviour Research and Therapy, 23, 325-335.

Thorén, P., Åsberg, M., Cronholm, B., Jörnestedt, L., et Träskman, L. (1980). Clomipramine treatment of obsessive-compulsive disorder: A controlled clinical trial. Archives of General Psychiatry, 37, 1281-1285.

Tollefson, G.D., Rampey, A.H., Potvin, J.H., Jenike, M.A., Rush, A.J., Dominguez, R.A., Koran, L.M., Shear, M.K., Goodman, W., et Genduso, L.A. (1994). A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Archives of General Psychiatry, 51, 559-567.

Van Ameringen, M., Mancini, C., Styan, G., et Donison, D. (1991). Relationship of social phobia with other psychiatric illness. Journal of Affective Disorders, 21, 93-99.

Van Balkom, A.J., van Oppen, P., Vermeulen, A.W., et van Dyck, R. (1994). A meta-analysis on the treatment of obsessive- compulsive disorder: A comparison of antidepressants, behavior, and cognitive therapy. Clinical Psychology Review, 14, 359-381.

Welkowitz, L.A., Papp, L.A., Cloitre, M., Liebowitz, M.R., Martin, L.Y., et Gorman, J.M. (1991). Cognitive-behavioral therapy for panic disorder delivered by psychopharmacologically-oriented clinicians. Journal of Nervous and Mental Disease, 179, 473-477.

Prochaine | Précédente | Table des matières